Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

BACKGROUND: The natural history of prostate cancer is highly variable and difficult to predict accurately. Better markers are needed to guide management and avoid unnecessary treatment. In this study, we validate the prognostic value of a cell cycle progression score (CCP score) independently and in...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Cancer
Auteurs principaux: Cuzick, J, Stone, S, Fisher, G, Yang, Z H, North, B V, Berney, D M, Beltran, L, Greenberg, D, Møller, H, Reid, J E, Gutin, A, Lanchbury, J S, Brawer, M, Scardino, P
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522632/
https://ncbi.nlm.nih.gov/pubmed/26103570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.223
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires